EUCTR2005-002454-21-IT进行中（未招募）不适用
A 2-year study 8 1-year weight loss followed by 1-year prevention of weight regain9 TO ASSESS THE SAFETY, TOLERABILITY AND EFFICACY OF l-000899055 in obese patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 2,400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A 2-Year Study (1-Year Weight Loss Followed by 1-Year Prevention of Weight Regain) to Assess the Safety, Tolerability and Efficacy of L-000899055 in Obese Patients - L-000899055: 1-Yr Weight Loss Followed by 1-Yr Prevention of Weight RegaiMedDRA version: 7.1Level: LLTClassification code 10029883ObesityEUCTR2005-002454-21-IEMerck Sharp and Dohme Ltd2,400
进行中（未招募）
不适用
A 2-Year Study (1-Year Weight Loss Followed by 1-Year Prevention of Weight Regain) to Assess the Safety, Tolerability and Efficacy of Taranabant (MK-0364) in Obese Patients Followed by a 1-Year Extension - Taranabant: 1-Yr Weight Loss Followed by 1-Yr Prevention of Weight Regain with 1-Year ExtensioMedDRA version: 7.1Level: LLTClassification code 10029883ObesityEUCTR2005-002454-21-SEMerck Sharp & Dohme (Sweden) AB2,420
进行中（未招募）
不适用
A 2-Year Study (1-Year Weight Loss Followed by 1-Year Prevention of Weight Regain) to Assess the Safety, Tolerability and Efficacy of L-000899055 in Obese Patients - L-000899055: 1-Yr Weight Loss Followed by 1-Yr Prevention of Weight RegaiObesityEUCTR2005-002454-21-HUMerck & Co., Inc.2,400
进行中（未招募）
1 期
A 2-Year Study (1-Year Weight Loss Followed by 1-Year Prevention of Weight Regain) to Assess the Safety, Tolerability and Efficacy of Taranabant (MK-0364) in Obese Patients followed by a 1 year extension. - MK-0364: 1-Yr Weight Loss Followed by 1-Yr Prevention of Weight RegaiMedDRA version: 7.1Level: LLTClassification code 10029883ObesityEUCTR2005-002454-21-GBMerck Sharp and Dohme Ltd2,400
已完成
3 期
Obese Patients With or Without Comorbidities (RIO-North America)Weight LossObesityNCT00029861Sanofi3,045